increase in mortality and more advanced disease features in the wide spectrum of benign (most notably cardiovascular) and malignant disorders [4] [5] [6] . It reflects an increase in levels of circulatory cytokines such as interleukin-6 and hepcidin [7, 8] , as well as C-reactive protein (CRP) and the erythrocyte sedimentation rate [9] , thus being recognized as a marker of subclinical systemic inflammation. Anisocytosis is a feature of PMF (where the disease pathogenesis supersedes inflammation as its only cause). However, the prognostic role of anisocytosis has not yet been studied in patients with PMF or other chronic myeloproliferative neoplasms. In this study, we present the association of increased RDW values with a decreased overall survival (OS) in newly diagnosed PMF patients and provide a correlation with disease features and the established prognostic score (IPSS).
This study was approved by the review board of University Hospital Dubrava. All subjects in whom molecular studies were performed provided written informed consent. We analyzed a group of 33 newly diagnosed patients with PMF who presented to our institution from 2004 to 2015. The diagnosis was established according to WHO criteria [10] . Patients with leukemic transformaPrimary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm driven by clonal expansion of pluripotent hematopoietic stem cells [1] . An abundance of proinflammatory cytokines released by tumor cells leads to reactive fibrosis in bone marrow, the production of often bizarrely shaped red cells (dacryocytes), and activation of extramedullary hematopoiesis, mostly in the spleen and the liver. The survival of PMF patients varies from several months to several years, and risk stratification is achieved using several prognostic scoring systems; the International Prognostic Scoring System (IPSS) [2] is preferred at the time of diagnosis. The IPSS evaluates the initial presence of 5 risk factors (1 point for each: age over 65 years, hemoglobin level below 10 g/dl, white blood cells elevated above 25 × 10 9 /l, 1% or more circulating blasts, and presence of constitutional symptoms).
The red cell distribution width (RDW) is a measure of the variability of erythrocyte volume [3] , and it is routinely reported by automated cell counters as part of the red blood cell count. It represents a quantitative measure of anisocytosis. The upper normal limit commonly approximates 15%, and this value is also used as a cut-off in our laboratory. An elevated RDW is associated with an performed using the methods of Kaplan and Meier, the log-rank test, and Cox's regression analysis. All statistical tests were 2-sided and p < 0.05 was considered statistically significant. The patients' characteristics are shown in table 1 .
Elevated RDW values were present in all PMF patients, with a median RDW of 19.0% (range 15.2-22.5%). RDW correlated significantly with hemoglobin level (r = -0.48, p = 0.005), CRP (r = 0.42, p = 0.031), and spleen size (r = 0.37, p = 0.036). Significant correlation was present between RDW and IPSS score (r = 0.51, p = 0.003). No correlation was found according to the age or sex of the patients, the degree of bone marrow fibrosis, JAK2 V617F mutational status, white blood cells, the percentage of circulatory blasts, platelet counts, MCV, LDH, or iron metabolism parameters. This means that both the RDW and the IPSS reflect similar processes associated with more advanced features of disease. During follow-up, considerable variations in RDW in both directions were observed in individual patients and were associated with the specific therapy used (hydroxyurea, ruxolitinib, splenectomy, or spleen irradiation), disease progression, septic complications, bleeding, and transfusion support, thus making RDW an unsuitable parameter to monitor the disease activity over time.
The median OS was 42 months, with a median followup of 28 months. A median RDW value of 19.0% was used as the cut-off to discriminate the very-high-RDW group ( ≥ 19.0%) from the high-RDW group (15.1-18.9%) and to show significant differences in OS between the two groups (HR 5.37, p = 0.002; fig. 1 ); the median OS was 23 and 89 months for the very-high-RDW and high-RDW groups, respectively.
In the univariate Cox regression analysis, RDW (p = 0.0026), IPSS score (p = 0.0151), CRP (p = 0.0025), LDH (p = 0.0285), and hemoglobin level (p = 0.04) were significantly associated with OS. RDW remained significantly associated with OS (HR 3.16, p = 0.002) in a multivariate Cox regression analysis model including IPSS score, CRP, hemoglobin level, and RDW ( table 1 ) and independently contributed to the prognosis; the choice of variables was based on associations with RDW and OS.
Therefore, the RDW represents a good integrative measure of different disease processes and also bears a prognostic significance at the time of PMF diagnosis. It encompasses a standard prognostic score (IPSS) and may help in the rapid detection of patients with an unfavorable prognosis. Our preliminary observations are limited by the small number of patients and need to be evaluated in larger studies.
